New York, NY, United States of America

Vijay Yajnik

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: New York University. Active years: 1998.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vijay Yajnik: Innovator in Cellular Signal Transduction

Introduction

Vijay Yajnik is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cellular biology, particularly in the area of signal transduction. His innovative work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Vijay Yajnik holds a patent for "Methods for treatment or diagnosis of diseases or disorders associated." This invention focuses on methods for diagnosing and treating diseases characterized by abnormal cellular signal transduction. The patent highlights a newly identified region termed the 'APB domain.' The binding of proteins within the APB domain is believed to play a crucial role in signal transduction pathways, influencing various cellular events. Agents that modulate APB-mediated activity can potentially be used to treat diseases involving proteins containing APB domains. He has 1 patent to his name.

Career Highlights

Vijay Yajnik is affiliated with New York University, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical science and therapeutic interventions.

Collaborations

Some of his notable coworkers include Benjamin L. Margolis and Joseph Schlessinger. Their collaborative efforts contribute to the ongoing research and development in cellular signal transduction.

Conclusion

Vijay Yajnik's innovative work in the field of cellular biology and his patent on the APB domain highlight his contributions to medical science. His research has the potential to influence future treatments for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…